These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 26576201)

  • 41. A thoracic tuberculous spondylodisctis after intravesical BCG immunotherapy of bladder cancer - Case report and literature review.
    Dąbrowska M; Drabarek T; Muraszko-Klaudel A; Sławek J
    Neurol Neurochir Pol; 2015; 49(6):460-6. PubMed ID: 26652884
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mycobacterial Osteomyelitis of the Spine Following Intravesical BCG Therapy for Bladder Cancer.
    Mackel CE; Burke SM; Huhta T; Riesenburger R; Weller SJ
    Cureus; 2016 Mar; 8(3):e545. PubMed ID: 27158574
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A CASE OF INTRAVESICAL BACILLUS CALMETTE-GUERIN-RELATED ENDOPHTHALMITIS AND RETINITIS CONFIRMED WITH RETINAL BIOPSY.
    Huggins A; Adam M; Ehmann D; Eagle RC; Malloy B; Garg SJ
    Retin Cases Brief Rep; 2019; 13(4):333-336. PubMed ID: 28644177
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A mycotic aneurysm of the abdominal aorta caused by
    Roeke T; Hovsibian S; Schlejen PM; Dinant S; Koster T; Waasdorp EJ
    J Vasc Surg Cases Innov Tech; 2018 Jun; 4(2):122-125. PubMed ID: 29942898
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tuberculous Orchitis Following Intravesical Bacille Calmette-Guérin (BCG) Therapy.
    Klebanov N; Raghavan A
    Cureus; 2018 May; 10(5):e2703. PubMed ID: 30062077
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Case report: Mycobacterium bovis orchitis post intravesical Bacillus Calmette Guerin.
    Samannodi M; Villavicencio A; Zhao A; Chavez V; Ericsson CD
    IDCases; 2018; 14():e00465. PubMed ID: 30479960
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mycobacterium bovis discitis as a complication of intravesical Bacillus Calmette-Guérin therapy.
    Colebatch AN; Mounce KE
    J Clin Rheumatol; 2010 Mar; 16(2):74-5. PubMed ID: 20130477
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tuberculous spondylitis as a complication of intravesical bacillus Calmette-Guerin therapy.
    Fishman JR; Walton DT; Flynn NM; Benson DR; deVere White RW
    J Urol; 1993 Mar; 149(3):584-7. PubMed ID: 8437271
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Upper tract urothelial carcinoma following intravesical bacillus Calmette-Guérin therapy for nonmuscle-invasive bladder cancer: Results from a multi-institutional retrospective study.
    Nishiyama N; Hotta H; Takahashi A; Yanase M; Itoh N; Tachiki H; Miyao N; Matsukawa M; Kunishima Y; Taguchi K; Kitamura H; Masumori N
    Urol Oncol; 2018 Jun; 36(6):306.e9-306.e15. PubMed ID: 29550096
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Aorto-enteric fistula development secondary to mycotic abdominal aortic aneurysm following intravesical bacillus Calmette-Guerin (BCG) treatment for transitional cell carcinoma of the bladder.
    Roylance A; Mosley J; Jameel M; Sylvan A; Walker V
    Int J Surg Case Rep; 2013; 4(1):88-90. PubMed ID: 23127864
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adverse reactions related to treatment compliance during BCG maintenance therapy for non-muscle-invasive bladder cancer.
    Miyazaki J; Hinotsu S; Ishizuka N; Naito S; Ozono S; Akaza H; Nishiyama H
    Jpn J Clin Oncol; 2013 Aug; 43(8):827-34. PubMed ID: 23858038
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Disseminated infection due to Mycobacterium bovis after intravesical BCG instillation.
    Marquez-Batalla S; Fraile-Villarejo E; Belhassen-García M; Gutierrez-Zubiaurre N; Cordero-Sánchez M
    World J Clin Cases; 2014 Jul; 2(7):301-3. PubMed ID: 25032208
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tuberculous Spondylitis following Intravesical Bacillus Calmette-Guerin for Bladder Cancer.
    Miyazaki M; Yoshiiwa T; Ishihara T; Kawano M; Tsumura H
    Case Rep Orthop; 2016; 2016():6741284. PubMed ID: 27313927
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Back pain following instillations of BCG for superficial bladder cancer is not a reactive complication: review of 30 Mycobacterium bovis BCG vertebral osteomyelitis cases.
    Cadiou S; Al Tabaa O; Nguyen CD; Faccin M; Guillin R; Revest M; Guggenbuhl P; Houvenagel E; Pertuiset E; Coiffier G
    Clin Rheumatol; 2019 Jun; 38(6):1773-1783. PubMed ID: 30868320
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of intravesical therapy with platelet-rich plasma (PRP) and Bacillus Calmette-Guérin (BCG) in non-muscle invasive bladder cancer.
    Dias LP; Luzo ÂCM; Volpe BB; Durán M; Galdames SEM; Ferreira LAB; Durán N; Fávaro WJ
    Tissue Cell; 2018 Jun; 52():17-27. PubMed ID: 29857824
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mycobacteremia and granulomatous hepatitis following initial intravesical bacillus Calmette-Guerin instillation for bladder carcinoma.
    Proctor DD; Chopra S; Rubenstein SC; Jokela JA; Uhl L
    Am J Gastroenterol; 1993 Jul; 88(7):1112-5. PubMed ID: 8317415
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Infected total hip arthroplasty after intravesical bacillus Calmette-Guérin therapy.
    Segal A; Krauss ES
    J Arthroplasty; 2007 Aug; 22(5):759-62. PubMed ID: 17689788
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Aortobisiliac graft thrombosis in bacillus Calmette-Guérin disseminated infection with graft involvement.
    Ciofani L; Milani R; Giordano J; Cevolani M
    J Vasc Surg Cases Innov Tech; 2024 Aug; 10(4):101504. PubMed ID: 38818509
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tuberculous Granuloma in the Scrotal Skin After Intravesical Bacillus Calmette-Guerin Therapy for Bladder Cancer: A Case Report.
    Shimura H; Ihara T; Mitsui T; Takeda M
    Urol Case Rep; 2017 Feb; 11():4-6. PubMed ID: 28083473
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tuberculous Spondylitis Caused by Intravesical Bacillus Calmette-Guerin Therapy.
    Minakata T; Nakano Y; Tamura S; Kazuki Y; Hayakawa K; Hayakawa T; Oota T; Fuzimoto T; Yamano Y; Takii T
    Intern Med; 2020; 59(5):733-737. PubMed ID: 32115520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.